Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

CBST 61.05 -0.61 (-0.99%)
price chart
Insider Selling: Steven C. Gilman Sells 40625 Shares of Cubist Pharmaceuticals ...
Cubist Pharmaceuticals (NASDAQ:CBST) traded up 0.24% during mid-day trading on Tuesday, hitting $61.55. 1,050,994 shares of the company's stock traded hands. Cubist Pharmaceuticals has a one year low of $55.71 and a one year high of $82.12.
Hot Stocks : Plug Power Inc. (NASDAQ:PLUG), Cubist Pharmaceuticals Inc ...
Plug Power Inc. (NASDAQ:PLUG)'s shares declined 2.60% to $5.62. The company on July 29 confirms the company has received a follow-on GenKey purchase order from Wal-Mart Stores, Inc. to add an additional, seventh, GenKey site to the original six-site ...
Cubist Pharmaceuticals Given Consensus Rating of �Buy� by Brokerages ...
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) has been given a consensus rating of �Buy� by the fifteen ratings firms that are covering the company, AnalystRatings.Net reports. Five research analysts have rated the stock with a hold ...
Analyst Update: EMC Corporation, Teva Pharmaceutical Industries Ltd (ADR ...
Meanwhile, among the equities in focus are tech issue EMC Corporation (NYSE:EMC), as well as drug makers Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Cubist Pharmaceuticals Inc (NASDAQ:CBST), which have all attracted analyst ...
Related articles »  
Cubist Pharmaceuticals Inc.: Cubist Reports Second Quarter 2014 Financial ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the second quarter ended June 30, 2014.
JMP Securities Downgrades Cubist Pharmaceuticals to Market Perform (CBST)  Intercooler
Cubist Reports Second Quarter 2014 Financial Results  Wall Street Journal
Related articles »  
Cubist Pharmaceuticals Rating Lowered to Market Perform at JMP Securities ...
Cubist Pharmaceuticals Inc logo Cubist Pharmaceuticals (NASDAQ:CBST) was downgraded by research analysts at JMP Securities from an �outperform� rating to a �market perform� rating in a report released on Wednesday, TheFlyOnTheWall.
Active Biotech Stocks in Concerns- MannKind Corporation (NASDAQ:MNKD ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) [Trend Analysis] has second quarter 2014 earnings (excluding special items) of 23 cents per share dropped well short of the Zacks Consensus anticipates of 37 cents due to lesser than anticipated revenues.
Related articles »  
Hot Stocks - Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), MannKind. (NASDAQ ...
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) second quarter 2014 earnings (excluding special items) of 23 cents per share fell well short of the Zacks Consensus Estimate of 37 cents due to lower-than-expected revenues.
Cubist Pharmaceuticals Lowered to Market Perform at JMP Securities (CBST)
Cubist Pharmaceuticals Inc logo JMP Securities cut shares of Cubist Pharmaceuticals (NASDAQ:CBST) from an outperform rating to a market perform rating in a research note issued to investors on Wednesday, TheFlyOnTheWall.
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments ...
Today, Analysts Review released its research reports regarding Cubist Pharmaceuticals Inc. (NASDAQ:CBST) , Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) , InterMune, Inc. (NASDAQ:ITMN) , NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) ...
Related articles »